Your browser doesn't support javascript.
loading
The stage-specifically accelerated brain aging in never-treated first-episode patients with depression.
Han, Shaoqiang; Chen, Yuan; Zheng, Ruiping; Li, Shuying; Jiang, Yu; Wang, Caihong; Fang, Keke; Yang, Zhengui; Liu, Liang; Zhou, Bingqian; Wei, Yarui; Pang, Jianyue; Li, Hengfen; Zhang, Yong; Cheng, Jingliang.
Afiliação
  • Han S; Department of Magnetic Resonance Imaging, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Chen Y; Key Laboratory for Functional Magnetic Resonance Imaging and Molecular Imaging of Henan Province, Zhengzhou, China.
  • Zheng R; Engineering Technology Research Center for Detection and Application of Brain Function of Henan Province, Zhengzhou, China.
  • Li S; Engineering Research Center of Medical Imaging Intelligent Diagnosis and Treatment of Henan Province, Zhengzhou, China.
  • Jiang Y; Key Laboratory of Magnetic Resonance and Brain Function of Henan Province, Zhengzhou, China.
  • Wang C; Key Laboratory of Brain Function and Cognitive Magnetic Resonance Imaging of Zhengzhou, Zhengzhou, China.
  • Fang K; Key Laboratory of Imaging Intelligence Research Medicine of Henan Province.
  • Yang Z; Department of Magnetic Resonance Imaging, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Liu L; Key Laboratory for Functional Magnetic Resonance Imaging and Molecular Imaging of Henan Province, Zhengzhou, China.
  • Zhou B; Engineering Technology Research Center for Detection and Application of Brain Function of Henan Province, Zhengzhou, China.
  • Wei Y; Engineering Research Center of Medical Imaging Intelligent Diagnosis and Treatment of Henan Province, Zhengzhou, China.
  • Pang J; Key Laboratory of Magnetic Resonance and Brain Function of Henan Province, Zhengzhou, China.
  • Li H; Key Laboratory of Brain Function and Cognitive Magnetic Resonance Imaging of Zhengzhou, Zhengzhou, China.
  • Zhang Y; Key Laboratory of Imaging Intelligence Research Medicine of Henan Province.
  • Cheng J; Department of Magnetic Resonance Imaging, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Hum Brain Mapp ; 42(11): 3656-3666, 2021 08 01.
Article em En | MEDLINE | ID: mdl-33932251
ABSTRACT
Depression associated with structural brain abnormalities is hypothesized to be related with accelerated brain aging. However, there is far from a unified conclusion because of clinical variations such as medication status, cumulative illness burden. To explore whether brain age is accelerated in never-treated first-episode patients with depression and its association with clinical characteristics, we constructed a prediction model where gray matter volumes measured by voxel-based morphometry derived from T1-weighted MRI scans were treated as features. The prediction model was first validated using healthy controls (HCs) in two Chinese Han datasets (Dataset 1, N = 130 for HCs and N = 195 for patients with depression; Dataset 2, N = 270 for HCs) separately or jointly, then the trained prediction model using HCs (N = 400) was applied to never-treated first-episode patients with depression (N = 195). The brain-predicted age difference (brain-PAD) scores defined as the difference between predicted brain age and chronological age, were calculated for all participants and compared between patients with age-, gender-, educational level-matched HCs in Dataset 1. Overall, patients presented higher brain-PAD scores suggesting patients with depression having an "older" brain than expected. More specially, this difference occurred at illness onset (illness duration <3 months) and following 2 years then disappeared as the illness further advanced (>2 years) in patients. This phenomenon was verified by another data-driven method and significant correlation between brain-PAD scores and illness duration in patients. Our results reveal that accelerated brain aging occurs at illness onset and suggest it is a stage-dependent phenomenon in depression.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Progressão da Doença / Senilidade Prematura / Transtorno Depressivo / Substância Cinzenta Tipo de estudo: Etiology_studies / Prognostic_studies Limite: Adolescent / Adult / Child / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Progressão da Doença / Senilidade Prematura / Transtorno Depressivo / Substância Cinzenta Tipo de estudo: Etiology_studies / Prognostic_studies Limite: Adolescent / Adult / Child / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article